研究成果の検索

検索コンセプト
選択されたフィルター

出版年

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

著者

  • Isamu Okamoto
2020

Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitors

Takada, K., Yoneshima, Y., Tanaka, K., Okamoto, I., Shimokawa, M., Wakasu, S., Takamori, S., Toyokawa, G., Oba, T., Osoegawa, A., Tagawa, T., Oda, Y., Nakanishi, Y. & Mori, M., 1 1 2020, (受理済み/印刷中) : : Journal of Cancer Research and Clinical Oncology.

研究成果: ジャーナルへの寄稿記事

Design and Rationale for a Phase III, Randomized, Placebo-controlled Trial of Durvalumab With or Without Tremelimumab After Concurrent Chemoradiotherapy for Patients With Limited-stage Small-cell Lung Cancer: The ADRIATIC Study

Senan, S., Okamoto, I., Lee, G. W., Chen, Y., Niho, S., Mak, G., Yao, W., Shire, N., Jiang, H. & Cho, B. C., 3 2020, : : Clinical Lung Cancer. 21, 2, p. e84-e88

研究成果: ジャーナルへの寄稿記事

公開

Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy

Tokudome, N., Koh, Y., Akamatsu, H., Fujimoto, D., Okamoto, I., Nakagawa, K., Hida, T., Imamura, F., Morita, S. & Yamamoto, N., 2 6 2020, : : BMC Cancer. 20, 1, 103.

研究成果: ジャーナルへの寄稿記事

公開

Longitudinal monitoring of somatic genetic alterations in circulating cell-free DNA during treatment with epidermal growth factor receptor–tyrosine kinase inhibitors

Iwama, E., Sakai, K., Hidaka, N., Inoue, K., Fujii, A., Nakagaki, N., Ota, K., Toyozawa, R., Azuma, K., Nakatomi, K., Harada, T., Hisasue, J., Sakata, S., Shimose, T., Kishimoto, J., Nakanishi, Y., Nishio, K. & Okamoto, I., 1 1 2020, : : Cancer. 126, 1, p. 219-227 9 p.

研究成果: ジャーナルへの寄稿記事

2 引用 (Scopus)

Multiclonality and Radiosensitivity of Granulocyte-colony Stimulating Factor-Producing Lung Adenocarcinoma Positive for an Activating EGFR Mutation

Tsutsumi, H., Yoneshima, Y., Ota, K., Otsubo, K., Iwama, E., Inoue, H., Tanaka, K., Nakanishi, Y. & Okamoto, I., 1 2020, : : Clinical Lung Cancer. 21, 1, p. e21-e24

研究成果: ジャーナルへの寄稿記事

Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M–positive non–small cell lung cancer: West Japan Oncology Group 8815L/LPS study

Takahama, T., Azuma, K., Shimokawa, M., Takeda, M., Ishii, H., Kato, T., Saito, H., Daga, H., Tsuboguchi, Y., Okamoto, I., Otsubo, K., Akamatsu, H., Teraoka, S., Takahashi, T., Ono, A., Ohira, T., Yokoyama, T., Sakai, K., Yamamoto, N., Nishio, K. および1人, Nakagawa, K., 1 1 2020, (受理済み/印刷中) : : Cancer.

研究成果: ジャーナルへの寄稿記事

Real-world effectiveness and safety of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study in Japan

Morita, R., Okishio, K., Shimizu, J., Saito, H., Sakai, H., Kim, Y. H., Hataji, O., Yomota, M., Nishio, M., Aoe, K., Kanai, O., Kumagai, T., Kibata, K., Tsukamoto, H., Oizumi, S., Fujimoto, D., Tanaka, H., Mizuno, K., Masuda, T., Kozuki, T. および6人, Haku, T., Suzuki, H., Okamoto, I., Hoshiyama, H., Ueda, J. & Ohe, Y., 2 2020, : : Lung Cancer. 140, p. 8-18 11 p.

研究成果: ジャーナルへの寄稿記事

公開

Therapies after first-line afatinib in patients with EGFR m+ NSCLC in Japan: Retrospective analysis of LUX-Lung 3

Yoshioka, H., Kato, T., Okamoto, I., Tanaka, H., Hida, T., Seto, T., Kiura, K., Tian, Y., Azuma, H. & Yamamoto, N., 1 1 2020, : : Future Oncology. 16, 4, p. 49-60 12 p.

研究成果: ジャーナルへの寄稿記事

公開
2019

18F-FDG uptake in PET/CT is a potential predictive biomarker of response to anti-PD-1 antibody therapy in non-small cell lung cancer

Takada, K., Toyokawa, G., Yoneshima, Y., Tanaka, K., Okamoto, I., Shimokawa, M., Wakasu, S., Haro, A., Osoegawa, A., Tagawa, T., Oda, Y., Nakanishi, Y. & Mori, M., 12 1 2019, : : Scientific reports. 9, 1, 13362.

研究成果: ジャーナルへの寄稿記事

公開
1 引用 (Scopus)

A Clinicopathological and Prognostic Analysis of PD-L2 Expression in Surgically Resected Primary Lung Squamous Cell Carcinoma

Matsubara, T., Takada, K., Azuma, K., Takamori, S., Toyokawa, G., Haro, A., Osoegawa, A., Tagawa, T., Kawahara, A., Akiba, J., Okamoto, I., Nakanishi, Y., Oda, Y., Hoshino, T. & Maehara, Y., 6 15 2019, : : Annals of Surgical Oncology. 26, 6, p. 1925-1933 9 p.

研究成果: ジャーナルへの寄稿記事

5 引用 (Scopus)

Association between peripheral blood markers and immune-related factors on tumor cells in patients with resected primary lung adenocarcinoma

Takada, K., Shimokawa, M., Tanaka, K., Kohashi, K., Haro, A., Osoegawa, A., Tagawa, T., Azuma, K., Okamoto, I., Oda, Y. & Mori, M., 6 2019, : : PloS one. 14, 6, e0217991.

研究成果: ジャーナルへの寄稿記事

公開

Clinical significance of monitoring EGFR mutation in plasma using multiplexed digital PCR in EGFR mutated patients treated with afatinib (West Japan Oncology Group 8114LTR study)

Akamatsu, H., Koh, Y., Okamoto, I., Fujimoto, D., Bessho, A., Azuma, K., Morita, S., Yamamoto, N. & Nakagawa, K., 5 2019, : : Lung Cancer. 131, p. 128-133 6 p.

研究成果: ジャーナルへの寄稿記事

公開
3 引用 (Scopus)
12 引用 (Scopus)

Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small-cell lung cancer

Yoshioka, H., Shimokawa, M., Seto, T., Morita, S., Yatabe, Y., Okamoto, I., Tsurutani, J., Satouchi, M., Hirashima, T., Atagi, S., Shibata, K., Saito, H., Toyooka, S., Yamamoto, N., Nakagawa, K. & Mitsudomi, T., 12 1 2019, : : Annals of Oncology. 30, 12, p. 1978-1984 7 p.

研究成果: ジャーナルへの寄稿記事

1 引用 (Scopus)

First-line afatinib for the treatment of EGFR mutation-positive non-small-cell lung cancer in the ‘real-world’ clinical setting

Park, K., Wan-Teck Lim, D., Okamoto, I. & Yang, J. C. H., 4 1 2019, : : Therapeutic Advances in Medical Oncology. 11

研究成果: ジャーナルへの寄稿評論記事

公開
2 引用 (Scopus)

Genetic Profiling of Non-Small Cell Lung Cancer at Development of Resistance to First- or Second-Generation EGFR-TKIs by CAPP-Seq Analysis of Circulating Tumor DNA

Otsubo, K., Sakai, K., Takeshita, M., Harada, D., Azuma, K., Ota, K., Akamatsu, H., Goto, K., Horiike, A., Kurata, T., Nakagaki, N., Nosaki, K., Iwama, E., Nakanishi, Y., Nishio, K. & Okamoto, I., 1 1 2019, : : Oncologist. 24, 8, p. 1022-1026 5 p.

研究成果: ジャーナルへの寄稿記事

Heregulin expression and its clinical implication for patients with EGFR-mutant non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitors

Yonesaka, K., Iwama, E., Hayashi, H., Suzuki, S., Kato, R., Watanabe, S., Takahama, T., Tanizaki, J., Tanaka, K., Takeda, M., Sakai, K., Azuma, K., Chiba, Y., Atagi, S., Nishio, K., Okamoto, I. & Nakagawa, K., 12 1 2019, : : Scientific reports. 9, 1, 19501.

研究成果: ジャーナルへの寄稿記事

公開

Identification of genomic alterations acquired during treatment with EGFR-TKIs in non-small cell lung cancer

Kubo, N., Harada, T., Shiraishi, Y., Nosaki, K., Nakagaki, N., Takeshita, M., Ouchi, H., Iwama, E., Tanaka, K., Okamoto, I., Sasaki, H. & Nakanishi, Y., 2 2019, : : Anticancer research. 39, 2, p. 671-677 7 p.

研究成果: ジャーナルへの寄稿記事

公開

Immune checkpoint protein and cytokine expression by T lymphocytes in pleural effusion of cancer patients receiving anti–PD-1 therapy

Ikematsu, Y., Tanaka, K., Yanagihara, T., Liu, R., Inoue, H., Yoneshima, Y., Ota, K., Iwama, E., Takata, S., Hata, K., Takahata, Y., Wataya, H., Nakanishi, Y. & Okamoto, I., 12 2019, : : Lung Cancer. 138, p. 58-64 7 p.

研究成果: ジャーナルへの寄稿記事

Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC

Sugawara, S., Nakagawa, K., Yamamoto, N., Nokihara, H., Ohe, Y., Nishio, M., Takahashi, T., Goto, K., Maemondo, M., Ichinose, Y., Seto, T., Sakai, H., Gemma, A., Imamura, F., Shingyoji, M., Saka, H., Inoue, A., Takeda, K., Okamoto, I., Kiura, K. および2人, Morita, S. & Tamura, T., 5 15 2019, : : International Journal of Clinical Oncology. 24, 5, p. 485-493 9 p.

研究成果: ジャーナルへの寄稿記事

公開

Localized malignant pleural mesothelioma mimicking an anterior mediastinal tumor

Hino, T., Kamitani, T., Sagiyama, K., Yamasaki, Y., Okamoto, I., Tagawa, T., Ijichi, K., Yamamoto, H., Yabuuchi, H. & Honda, H., 1 1 2019, : : European Journal of Radiology Open. 6, p. 72-77 6 p.

研究成果: ジャーナルへの寄稿記事

2 引用 (Scopus)

Molecularly-targeted therapies for advanced non-small-cell lung cancer

Okamoto, I., 11 25 2019, : : Japanese Journal of Lung Cancer. 59, p. 1115-1118 4 p.

研究成果: ジャーナルへの寄稿記事

Osimertinib for Japanese patients with T790M-positive advanced non-small-cell lung cancer: A pooled subgroup analysis

Hirashima, T., Satouchi, M., Hida, T., Nishio, M., Kato, T., Sakai, H., Imamura, F., Kiura, K., Okamoto, I., Kasahara, K., Uchida, H., Vowler, S. L. & Mitsudomi, T., 9 1 2019, : : Cancer Science. 110, 9, p. 2884-2893 10 p.

研究成果: ジャーナルへの寄稿記事

公開
2 引用 (Scopus)

Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset

Ohe, Y., Imamura, F., Nogami, N., Okamoto, I., Kurata, T., Kato, T., Sugawara, S., Ramalingam, S. S., Uchida, H., Hodge, R., Vowler, S. L., Walding, A. & Nakagawa, K., 1 1 2019, : : Japanese journal of clinical oncology. 49, 1, p. 29-36 8 p.

研究成果: ジャーナルへの寄稿記事

6 引用 (Scopus)

Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian Subset

Cho, B. C., Chewaskulyong, B., Lee, K. H., Dechaphunkul, A., Sriuranpong, V., Imamura, F., Nogami, N., Kurata, T., Okamoto, I., Zhou, C., Cheng, Y., Cho, E. K., Voon, P. J., Lee, J. S., Mann, H., Saggese, M., Reungwetwattana, T., Ramalingam, S. S. & Ohe, Y., 1 2019, : : Journal of Thoracic Oncology. 14, 1, p. 99-106 8 p.

研究成果: ジャーナルへの寄稿記事

6 引用 (Scopus)

Pemetrexed and carboplatin combination therapy followed by pemetrexed maintenance in Japanese patients with non-squamous non-small cell lung cancer: A subgroup analysis of elderly patients

Nogami, N., Nishio, M., Okamoto, I., Enatsu, S., Suzukawa, K., Takai, H., Nakagawa, K. & Tamura, T., 1 2019, : : Respiratory Investigation. 57, 1, p. 27-33 7 p.

研究成果: ジャーナルへの寄稿記事

1 引用 (Scopus)

Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer

Udagawa, H., Akamatsu, H., Tanaka, K., Takeda, M., Kanda, S., Kirita, K., Teraoka, S., Nakagawa, K., Fujiwara, Y., Yasuda, I., Okubo, S., Shintani, M., Kosloski, M. P., Scripture, C., Tamura, T. & Okamoto, I., 9 2019, : : Lung Cancer. 135, p. 145-150 6 p.

研究成果: ジャーナルへの寄稿記事

1 引用 (Scopus)

Prognostic Impact of Programmed Death-Ligand 2 Expression in Primary Lung Adenocarcinoma Patients

Takamori, S., Takada, K., Azuma, K., Jogo, T., Shimokawa, M., Toyokawa, G., Hirai, F., Tagawa, T., Kawahara, A., Akiba, J., Okamoto, I., Nakanishi, Y., Oda, Y., Hoshino, T. & Maehara, Y., 6 15 2019, : : Annals of Surgical Oncology. 26, 6, p. 1916-1924 9 p.

研究成果: ジャーナルへの寄稿記事

4 引用 (Scopus)

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

Nakagawa, K., Garon, E. B., Seto, T., Nishio, M., Ponce Aix, S., Paz-Ares, L., Chiu, C. H., Park, K., Novello, S., Nadal, E., Imamura, F., Yoh, K., Shih, J. Y., Au, K. H., Moro-Sibilot, D., Enatsu, S., Zimmermann, A., Frimodt-Moller, B., Visseren-Grul, C., Reck, M. および96人, Chu, Q., Cortot, A., Pujol, J. L., Fabre, E., Lamour, C., Bischoff, H., Kollmeier, J., Kimmich, M., Engel-Riedel, W., Hammerschmidt, S., Schütte, W., Syrigos, K., Ho, J. C. M., Au, K. H., Ardizzoni, A., Pasello, G., Gregorc, V., Del Conte, A., Galetta, D., Takahashi, T., Kumagai, T., Hotta, K., Goto, Y., Hosomi, Y., Sakai, H., Takiguchi, Y., Kim, Y. H., Kurata, T., Yamaguchi, H., Daga, H., Okamoto, I., Satouchi, M., Ikeda, S., Kasahara, K., Atagi, S., Azuma, K., Aoe, K., Horio, Y., Yamamoto, N., Tanaka, H., Watanabe, S., Nogami, N., Ozaki, T., Koyama, R., Hirashima, T., Kaneda, H., Tomii, K., Fujita, Y., Seike, M., Nishimura, N., Kato, T., Ichiki, M., Saka, H., Hirano, K., Nakahara, Y., Sugawara, S., Kim, S. W., Min, Y. J., Lee, H. W., Kang, J. H., An, H. J., Lee, K. H., Kim, J. S., Lee, G. W., Lee, S. Y., Alexandru, A., Udrea, A. A., Juan-Vidal, Ó., Nadal-Alforja, E., Gil-Bazo, I., Ponce-Aix, S., Rubio-Viqueira, B., Alonso Garcia, M., Felip Font, E., Fuentes Pradera, J., Coves Sarto, J., Lin, M. C., Su, W. C., Hsia, T. C., Chang, G. C., Wei, Y. F., Su, J., Cicin, I., Goksel, T., Harputluoglu, H., Ozyilkan, O., Henning, I., Popat, S., Hatcher, O., Mileham, K., Acoba, J., Garon, E., Jung, G., Raj, M., Martin, W. & Dakhil, S., 12 2019, : : The Lancet Oncology. 20, 12, p. 1655-1669 15 p.

研究成果: ジャーナルへの寄稿記事

4 引用 (Scopus)

Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201)

Fukuda, M., Kitazaki, T., Ogawara, D., Ichiki, M., Mukae, H., Maruyama, R., Nakagaki, N., Shimada, M., Ikeda, T., Kishimoto, J., Harada, T., Seto, T., Ebi, N., Takayama, K., Okamoto, I., Ichinose, Y. & Sugio, K., 6 2019, : : Lung Cancer. 132, p. 1-8 8 p.

研究成果: ジャーナルへの寄稿記事

Safety and efficacy of PD-1 inhibitors in non–small cell lung cancer patients positive for antinuclear antibodies

Yoneshima, Y., Tanaka, K., Shiraishi, Y., Hata, K., Watanabe, H., Harada, T., Otsubo, K., Iwama, E., Inoue, H., Masuda, S., Nakanishi, Y. & Okamoto, I., 4 2019, : : Lung Cancer. 130, p. 5-9 5 p.

研究成果: ジャーナルへの寄稿記事

2 引用 (Scopus)

Subgroup Analysis of Japanese Patients in a Phase III Study of Atezolizumab in Extensive-stage Small-cell Lung Cancer (IMpower133)

Nishio, M., Sugawara, S., Atagi, S., Akamatsu, H., Sakai, H., Okamoto, I., Takayama, K., Hayashi, H., Nakagawa, Y. & Kawakami, T., 11 2019, : : Clinical Lung Cancer. 20, 6, p. 469-476.e1

研究成果: ジャーナルへの寄稿記事

1 引用 (Scopus)

Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia

DLD/TO Assemblies of JRS, 11 2019, : : Respiratory Investigation. 57, 6, p. 512-533 22 p.

研究成果: ジャーナルへの寄稿評論記事

1 引用 (Scopus)

Survival Analysis for Patients with ALK Rearrangement-Positive Non-Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401

Iwama, E., Goto, Y., Murakami, H., Tsumura, S., Sakashita, H., Mori, Y., Nakagaki, N., Fujita, Y., Seike, M., Bessho, A., Ono, M., Nishitsuji, M., Akamatsu, H., Morinaga, R., Akagi, T., Shimose, T., Tokunaga, S., Yamamoto, N., Nakanishi, Y., Sugio, K. および1人, Okamoto, I., 1 1 2019, (受理済み/印刷中) : : Oncologist.

研究成果: ジャーナルへの寄稿記事

公開

Tissue and plasma EGFR mutation analysis in the FLAURA trial: Osimertinib versus Comparator EGFR tyrosine kinase inhibitor as first-line treatment in patients with EGFR-mutated advanced non–small cell lung cancer

Gray, J. E., Okamoto, I., Sriuranpong, V., Vansteenkiste, J., Imamura, F., Lee, J. S., Pang, Y. K., Cobo, M., Kasahara, K., Cheng, Y., Nogami, N., Cho, E. K., Su, W. C., Zhang, G., Huang, X., Li-Sucholeiki, X., Lentrichia, B., Dearden, S., Jenkins, S., Saggese, M. および2人, Rukazenkov, Y. & Ramalingam, S. S., 11 15 2019, : : Clinical Cancer Research. 25, 22, p. 6644-6652 9 p.

研究成果: ジャーナルへの寄稿記事

1 引用 (Scopus)

Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab-Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer

Tsuchiya-Kawano, Y., Sasaki, T., Yamaguchi, H., Hirano, K., Horiike, A., Satouchi, M., Hosokawa, S., Morinaga, R., Komiya, K., Inoue, K., Fujita, Y., Toyozawa, R., Kimura, T., Takahashi, K., Nishikawa, K., Kishimoto, J., Nakanishi, Y. & Okamoto, I., 1 1 2019, (受理済み/印刷中) : : Oncologist.

研究成果: ジャーナルへの寄稿記事

公開
2018

Anticancer drug treatment for advanced lung cancer with interstitial lung disease

Otsubo, K., Okamoto, I., Hamada, N. & Nakanishi, Y., 7 2018, : : Respiratory Investigation. 56, 4, p. 307-311 5 p.

研究成果: ジャーナルへの寄稿評論記事

3 引用 (Scopus)

Association of nephrotoxicity during platinum-etoposide doublet therapy with UGT1A1 polymorphisms in small cell lung cancer patients

Anai, S., Iwama, E., Yoneshima, Y., Otsubo, K., Tanaka, K., Nakanishi, Y. & Okamoto, I., 12 2018, : : Lung Cancer. 126, p. 156-161 6 p.

研究成果: ジャーナルへの寄稿記事

Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers

Akamine, T., Takada, K., Toyokawa, G., Kinoshita, F., Matsubara, T., Kozuma, Y., Haratake, N., Takamori, S., Hirai, F., Tagawa, T., Okamoto, T., Yoneshima, Y., Okamoto, I., Shimokawa, M., Oda, Y., Nakanishi, Y. & Maehara, Y., 3 2018, : : Surgical Oncology. 27, 1, p. 88-94 7 p.

研究成果: ジャーナルへの寄稿記事

12 引用 (Scopus)

Clinical significance of PD-L1 expression in brain metastases from non-small cell lung cancer

Takamori, S., Toyokawa, G., Okamoto, I., Takada, K., Kinoshita, F., Kozuma, Y., Matsubara, T., Haratake, N., Akamine, T., Mukae, N., Hirai, F., Tagawa, T., Oda, Y., Iwaki, T., Iihara, K., Nakanishi, Y. & Maehara, Y., 1 2018, : : Anticancer research. 38, 1, p. 553-557 5 p.

研究成果: ジャーナルへの寄稿記事

7 引用 (Scopus)

CNS response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non-small-cell lung cancer

Reungwetwattana, T., Nakagawa, K., Cho, B. C., Cobo, M., Cho, E. K., Bertolini, A., Bohnet, S., Zhou, C., Lee, K. H., Nogami, N., Okamoto, I., Leighl, N., Hodge, R., McKeown, A., Brown, A. P., Rukazenkov, Y., Ramalingam, S. S. & Vansteenkiste, J., 11 20 2018, : : Journal of Clinical Oncology. 36, 33, p. 3290-3297 8 p.

研究成果: ジャーナルへの寄稿記事

64 引用 (Scopus)

Combined therapy with epidermal growth factor receptor tyrosine kinase inhibitors for non–small cell lung cancer

Iwama, E., Nakanishi, Y. & Okamoto, I., 3 4 2018, : : Expert Review of Anticancer Therapy. 18, 3, p. 267-276 10 p.

研究成果: ジャーナルへの寄稿評論記事

4 引用 (Scopus)

Detection of identical T cell clones in peritumoral pleural effusion and pneumonitis lesions in a cancer patient during immune-checkpoint blockade

Tanaka, K., Yanagihara, T., Ikematsu, Y., Inoue, H., Ota, K., Kashiwagi, E., Suzuki, K., Hamada, N., Takeuchi, A., Tatsugami, K., Eto, M., Ijichi, K., Oda, Y., Otsubo, K., Yoneshima, Y., Iwama, E., Nakanishi, Y. & Okamoto, I., 7 17 2018, : : Oncotarget. 9, 55, p. 30587-30593 7 p.

研究成果: ジャーナルへの寄稿記事

5 引用 (Scopus)

Development of leptomeningeal carcinomatosis during a marked response of brain metastases to pembrolizumab in a patient with non-small-cell lung cancer

Otsubo, K., Seki, N., Nakanishi, Y. & Okamoto, I., 3 1 2018, : : Annals of Oncology. 29, 3, p. 780-781 2 p.

研究成果: ジャーナルへの寄稿レター

1 引用 (Scopus)

Durable response to nivolumab in a lung adenocarcinoma patient with idiopathic pulmonary fibrosis

Ide, M., Tanaka, K., Sunami, S., Asoh, T., Maeyama, T., Tsuruta, N., Nakanishi, Y. & Okamoto, I., 11 2018, : : Thoracic Cancer. 9, 11, p. 1519-1521 3 p.

研究成果: ジャーナルへの寄稿記事

4 引用 (Scopus)

Erlotinib Plus Bevacizumab Phase ll Study in Patients with Advanced Non-small-Cell Lung Cancer (JO25567): Updated Safety Results

Kato, T., Seto, T., Nishio, M., Goto, K., Yamamoto, N., Okamoto, I., Tao, L., Yu, W., Khaznadar, T., Tajima, K., Shibata, M., Seki, A. & Yamamoto, N., 2 1 2018, : : Drug Safety. 41, 2, p. 229-237 9 p.

研究成果: ジャーナルへの寄稿記事

12 引用 (Scopus)

Exploration of resistance mechanisms for epidermal growth factor receptor-tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next-generation sequencing

Iwama, E., Sakai, K., Azuma, K., Harada, D., Nosaki, K., Hotta, K., Nishio, M., Kurata, T., Fukuhara, T., Akamatsu, H., Goto, K., Shimose, T., Kishimoto, J., Nakanishi, Y., Nishio, K. & Okamoto, I., 12 2018, : : Cancer Science. 109, 12, p. 3921-3933 13 p.

研究成果: ジャーナルへの寄稿記事

9 引用 (Scopus)

Expression of brain-derived neurotrophic factor and its receptor TrkB is associated with poor prognosis and a malignant phenotype in small cell lung cancer

Kimura, S., Harada, T., Ijichi, K., Tanaka, K., Liu, R., Shibahara, D., Kawano, Y., Otsubo, K., Yoneshima, Y., Iwama, E., Nakanishi, Y. & Okamoto, I., 6 2018, : : Lung Cancer. 120, p. 98-107 10 p.

研究成果: ジャーナルへの寄稿記事

2 引用 (Scopus)

Heterogeneous distribution of alectinib in neuroblastoma xenografts revealed by matrix-assisted laser desorption ionization mass spectrometry imaging: a pilot study

Ryu, S., Hayashi, M., Aikawa, H., Okamoto, I., Fujiwara, Y. & Hamada, A., 1 2018, : : British Journal of Pharmacology. 175, 1, p. 29-37 9 p.

研究成果: ジャーナルへの寄稿記事

2 引用 (Scopus)